Study Comparing Transobturator Cystocele vs. Anterior Vaginal RepairS

Launched by CHARLES UNIVERSITY, CZECH REPUBLIC · Oct 31, 2022

Keywords

ClinConnect Summary

This clinical trial is studying two different surgical methods for treating a condition called cystocele, which is a type of pelvic organ prolapse where the bladder bulges into the vagina. The trial aims to compare a newer surgery called transobturator cystocele repair (TOCR) with a traditional method known as native tissue repair. Both procedures are designed to fix the support structure of the vagina to help relieve symptoms like a bulge sensation. Researchers want to find out which method is safer and more effective for women facing this issue.

To participate in the trial, women must be at least 50 years old and have a specific level of prolapse (at least stage 2) that causes symptoms. They should also be able to communicate in Czech or English. Participants will receive one of the two surgical treatments and will be monitored to see how well the surgery works and if there are any side effects. It's important to note that women with any type of cancer are not eligible for this study. Overall, this trial hopes to improve treatment options for women experiencing cystocele and help them feel better.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • (at least) 2nd stage prolapse of the anterior compartment (Ba ≥ -1)
• • Age ≥ 50 years
• • Symptom bulge
• • Ability to speak Czech or English
• Exclusion Criteria:
• • Malignancy